Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
about
Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosisA significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings.MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosisMR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.Combining atlas-based parcellation of regional brain data acquired across scanners at 1.5 T and 3.0 T field strengthsAn expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis.The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosisMRI in the assessment and monitoring of multiple sclerosis: an update on best practice.Variation in longitudinal trajectories of regional brain volumes of healthy men and women (ages 10 to 85 years) measured with atlas-based parcellation of MRI.Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7TRecommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosisWhole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.Magnetic field interactions of copper-containing intrauterine devices in 3.0-Tesla magnetic resonance imaging: in vivo study.Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.Electrophysiological correlates of decision making impairment in multiple sclerosis.Melanocortins, Melanocortin Receptors and Multiple Sclerosis.Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliabilityThe usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.MRI-Based Measurement of Brain Stem Cross-Sectional Area in Relapsing-Remitting Multiple Sclerosis.Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.Conventional and synthetic MRI in multiple sclerosis: a comparative study.Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting.
P2860
Q28295284-E48665A8-3F64-43D4-ABF8-60E3E33CAB33Q30575122-00C5C5DC-9854-471A-A601-3DA9552E9C24Q30977551-82A43407-4838-4CC7-9F33-74567FF17BFAQ33605353-F9E02D31-644F-4482-BDFA-4708D9DB94C6Q33769234-31EF7D2B-CADC-4BE9-A4F6-5336BA50EC92Q33928228-C21EF89F-C5FB-4289-847F-4764FED57800Q34053148-8E104CDE-3275-4AD9-8BF2-177C969BBF02Q34148406-315AF4E7-33C5-408A-B304-B7B5D857903AQ34197065-9B7678F0-C92E-4573-8C27-D109961ECC90Q34696441-7390014A-0DD0-4269-A6E2-16560CA3043EQ34904136-2EEF2BE3-E9F8-40D2-8DCD-C78CE16AE16DQ35082344-4C39C1BA-7516-4739-BDB0-D344C0488315Q35535764-E7110859-3FCB-4644-927D-C8E145F11308Q35937975-3C79D635-825D-43EB-90F2-D550CAF083E9Q36183159-CC94A56D-6297-424E-9ABF-643371D66338Q36400004-4519FDAB-7ED2-439E-9D63-0ACA253C155FQ36450971-725FE501-6415-4B14-BFD4-08A52AC55E31Q36495185-37C1614B-6342-426B-992B-59154EEB4321Q36538213-C5818089-D793-47D2-8E89-257C692B96A2Q36562595-1B16A915-D22A-43CD-816E-6356C0C83616Q36584411-3244D9E2-3A9B-4E46-926E-06D11C797908Q36847758-92602FDF-5CBF-4108-BE18-8BA76870D984Q36978709-C5FE8026-1330-41D5-9EEE-1E50610DDF70Q37048758-0306181E-CC30-46AC-B9E6-9746C5A6FD90Q37184527-4619C65A-E965-46A3-ABE4-F5AEDACCA7DDQ37247679-90C1E561-666B-4D55-809D-EBD2F637AB01Q37459099-AD1B0932-FD2C-4526-ADCB-B885567EA871Q38022219-E411D543-437D-499B-B283-CA8989FDA44AQ38713119-C5431E42-B52A-433E-BD34-429FF44BB1BCQ38837567-79829C48-95C6-48C6-8414-157677841D3BQ40423929-11930A57-6DC4-415C-B0C4-1657C66B33F0Q41552761-3236EF5B-A049-4161-805A-A4EF86B7176DQ41613266-E4D02950-FB1F-44E5-A08E-6C2F3941513AQ44061291-7893809D-8AFA-4702-B26B-48E35CB3726FQ47242221-E07C9F9C-1EEB-48B0-AA1E-D90AB0CC7E98Q48170481-A91642D8-EB48-486E-B093-5C00346E0F00Q48220840-E2F4EF6E-6B84-46B8-9CBD-511B48AF5BEBQ48258681-476806C0-C257-4E91-B39A-F318999FB6BBQ48310829-96739CF8-CBC0-438A-A9E3-BA256141C23DQ48361023-510D1217-E9AD-49E5-8EF0-54A1C4CC097A
P2860
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@ast
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@en
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@nl
type
label
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@ast
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@en
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@nl
prefLabel
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@ast
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@en
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
@nl
P2093
P2860
P50
P1476
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis
@en
P2093
Ashish Arora
Bonnie I Glanz
Brian C Healy
Guy J Buckle
James M Stankiewicz
Maria K Houtchens
Mohit Neema
Ralph H B Benedict
Rohit Bakshi
Shahamat Tauhid
P2860
P356
10.1111/J.1552-6569.2009.00449.X
P577
2011-04-01T00:00:00Z